Correlation Between Mineralys Therapeutics, and Zivo Bioscience

Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Zivo Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Zivo Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mineralys Therapeutics, Common and Zivo Bioscience, you can compare the effects of market volatilities on Mineralys Therapeutics, and Zivo Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Zivo Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Zivo Bioscience.

Diversification Opportunities for Mineralys Therapeutics, and Zivo Bioscience

0.0

Correlation Coefficient

Mineralys Therapeutics,  Zivo Bioscience

Pay attention - limited upside

The 3 months correlation between Mineralys and Zivo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Zivo Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zivo Bioscience and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Zivo Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zivo Bioscience has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Zivo Bioscience go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Zivo Bioscience

If you would invest  1,252  in Mineralys Therapeutics, Common on December 29, 2024 and sell it today you would earn a total of  248.00  from holding Mineralys Therapeutics, Common or generate 19.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Mineralys Therapeutics, Common  vs.  Zivo Bioscience

Mineralys Therapeutics,

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Mineralys Therapeutics, unveiled solid returns over the last few months and may actually be approaching a breakup point.

Zivo Bioscience

Risk-Adjusted Performance

Very Weak

Over the last 90 days Zivo Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Zivo Bioscience is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Mineralys Therapeutics, and Zivo Bioscience

The main advantage of trading using opposite Mineralys Therapeutics, and Zivo Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Zivo Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zivo Bioscience will offset losses from the drop in Zivo Bioscience's long position.

The idea behind Mineralys Therapeutics, Common and Zivo Bioscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.